BRIEF published on 08/11/2026 at 18:35, 24 days 9 hours ago Medincell at Piper Sandler CNS Symposium 2026 Investors Medincell BEPO Technology Piper Sandler CNS Symposium Prolonged Treatments
BRIEF published on 08/11/2026 at 18:35, 24 days 9 hours ago Medincell au Piper Sandler CNS Symposium 2026 Investisseurs Medincell Piper Sandler CNS Symposium BEPO Technologie Traitements Prolongés
PRESS RELEASE published on 08/11/2026 at 18:30, 24 days 9 hours ago Informations privilégiées / Autres communiqués Medincell participera au Piper Sandler CNS Symposium le 13 août 2026 avec le Dr Grace Kim, CSO, U.S. Finance. L'entreprise développe des traitements injectables à action prolongée pour divers domaines thérapeutiques Medincell Dr Grace Kim Action Prolongée Piper Sandler CNS Symposium Traitements Injectables
BRIEF published on 07/29/2026 at 13:29, 1 month 6 days ago Medincell Partner Teva Reports Strong UZEDY® Sales Growth Net Sales Growth Revenue Outlook Schizophrenia Treatment Teva Pharmaceuticals Long-acting Injectable
BRIEF published on 07/29/2026 at 13:29, 1 month 6 days ago Record sales for UZEDY® in the second quarter of 2026 Schizophrenia Teva Pharmaceuticals UZEDY Sales 2026 Forecast Medincell Royalties
BRIEF published on 07/29/2026 at 13:29, 1 month 6 days ago Ventes record pour UZEDY® au deuxième trimestre 2026 Schizophrénie Teva Pharmaceuticals Ventes UZEDY Prévisions 2026 Royalties Medincell
BRIEF published on 07/29/2026 at 13:29, 1 month 6 days ago Le partenaire de Medincell, Teva, annonce une forte croissance des ventes d'UZEDY® Croissance Des Ventes Nettes Traitement De La Schizophrénie Perspectives De Revenus Teva Pharmaceuticals Injectable À Action Prolongée
PRESS RELEASE published on 07/29/2026 at 13:24, 1 month 6 days ago Inside Information / Other news releases Teva's UZEDY® achieves record Q2 net sales of $77M, up 43% YoY. Olanzapine LAI FDA action anticipated in Q4 2026. Medincell's innovative long-acting injectable treatments show promising results Record Sales Medincell Teva UZEDY Long-acting Injectable
PRESS RELEASE published on 07/29/2026 at 13:24, 1 month 6 days ago Informations privilégiées / Autres communiqués Ventes record d'UZEDY® de 77 M$ au 2ème trimestre 2026 (+43% sur un an), Teva relève ses prévisions. Annonce sur les résultats de Teva : ir.tevapharm.com Schizophrénie Ventes Record Teva Pharmaceuticals UZEDY® Prévisions 2026
BRIEF published on 07/28/2026 at 20:26, 1 month 7 days ago Publication of the 2025/2026 Universal Registration Document by Medincell Financial Report General Assembly CSR Registration Document Medincell
Published on 09/04/2026 at 23:30, 4 hours 23 minutes ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 4 hours 53 minutes ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 5 hours 23 minutes ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 13 hours 23 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/04/2026 at 14:00, 13 hours 53 minutes ago Horizon Aircraft Appoints Tom Hearne to Board of Directors and Names Him Audit Committee Chair
Published on 09/04/2026 at 22:10, 5 hours 43 minutes ago Quantinuum to Participate in the Bernstein 23rd Annual Pan-European Strategic Decisions Conference
Published on 09/04/2026 at 19:20, 8 hours 33 minutes ago Dahua Technology Showcases Integrated Smart Living and Innovations at IFA Berlin 2026
Published on 09/04/2026 at 19:00, 8 hours 53 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:50, 9 hours 3 minutes ago A&S Resources secures railway funding of USD$6 Billion to unlock $2.5 trillion iron ore asset
Published on 09/04/2026 at 18:57, 8 hours 56 minutes ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 8 hours 56 minutes ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 9 hours 38 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 9 hours 38 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 9 hours 38 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
